UG logo

UNITED GUARDIAN INC

UGNASDAQ
πŸ† #3550 by market capUS Equity
$7.15β–Ό $0.13 (βˆ’1.79%)
Market closed Β· at close
1hβ€”
24hβ–Ό 1.8%
7dβ–² 0.3%
14dβ–Ό 13.4%
30dβ–Ό 0.8%
1yβ–Ό 11.2%
🏦Market Cap
$33M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-4.1%
Declining
πŸ“ŠGross Margin
47.6%
Healthy
πŸ’΅FCF Margin
20.0%
Healthy
βš–οΈP/S Ratio
3.1x
Fair
Otter Score
61
Fair

Trading Snapshot

Day Range
$7.04 – $7.20
52-Week Range
$5.58 – $8.78
Volume
$3.56B
Avg Volume
$3.87B
Shares Outstanding
4.6M
Next Earnings
Sep 25, 2026

Fundamentals Snapshot

Annual Revenue
$11M
Last Q Revenue
$3M
P/E Ratio
14.4
P/S Ratio
3.1x
EPS (TTM)
$0.51
Dividend Yield
6.78%

Why Investors Own UG

  • βœ“High-growth profile β€” revenue up +45.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 44% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$11Mβ–² +39.6% YoY
Gross Margin (TTM)
44.1%β–² +1.4% YoY
Operating Income (TTM)
$4Mβ–² +39.6% YoY
Free Cash Flow (TTM)
$2Mβ–² +39.6% YoY

About UNITED GUARDIAN INC

United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
61/100

Analyst Price Target

β“˜
Average Target
$8.94
β–² +25.0% Upside
High Target$11.24
Low Target$6.89
Based on 32 analysts

Latest News & Updates